ATE359811T1 - Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe - Google Patents

Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe

Info

Publication number
ATE359811T1
ATE359811T1 AT00954737T AT00954737T ATE359811T1 AT E359811 T1 ATE359811 T1 AT E359811T1 AT 00954737 T AT00954737 T AT 00954737T AT 00954737 T AT00954737 T AT 00954737T AT E359811 T1 ATE359811 T1 AT E359811T1
Authority
AT
Austria
Prior art keywords
vaccines
trehalose
prokaryotic cells
producing prokaryotic
producing
Prior art date
Application number
AT00954737T
Other languages
English (en)
Inventor
Camilo Anthony Leo Selw Colaco
Original Assignee
Immunobiology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd
Application granted granted Critical
Publication of ATE359811T1 publication Critical patent/ATE359811T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00954737T 1999-08-19 2000-08-18 Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe ATE359811T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9919732.9A GB9919732D0 (en) 1999-08-19 1999-08-19 Trehalose producing cells as vaccines

Publications (1)

Publication Number Publication Date
ATE359811T1 true ATE359811T1 (de) 2007-05-15

Family

ID=10859499

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954737T ATE359811T1 (de) 1999-08-19 2000-08-18 Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe

Country Status (10)

Country Link
US (1) US20070243200A1 (de)
EP (1) EP1204420B1 (de)
AT (1) ATE359811T1 (de)
AU (1) AU6709500A (de)
DE (1) DE60034460T2 (de)
DK (1) DK1204420T3 (de)
ES (1) ES2286033T3 (de)
GB (1) GB9919732D0 (de)
PT (1) PT1204420E (de)
WO (1) WO2001013942A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009126548A2 (en) * 2008-04-07 2009-10-15 Rich Products Corporation Method for preparing edible aquatic animals for storage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312909A (en) * 1990-03-28 1994-05-17 Gist Brocades, N.V. Recombinant DNA encoding neutral trehalase
US5422254A (en) * 1992-02-14 1995-06-06 Oy Alko Ab Method to increase the trehalose content of organisms by transforming them with the structural genes for the short and long chains of yeast trehalose synthase
US6468782B1 (en) * 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby

Also Published As

Publication number Publication date
PT1204420E (pt) 2007-07-20
DE60034460T2 (de) 2008-01-03
WO2001013942A3 (en) 2001-09-20
EP1204420A2 (de) 2002-05-15
DE60034460D1 (de) 2007-05-31
AU6709500A (en) 2001-03-19
US20070243200A1 (en) 2007-10-18
EP1204420B1 (de) 2007-04-18
WO2001013942A2 (en) 2001-03-01
GB9919732D0 (en) 1999-10-20
DK1204420T3 (da) 2007-09-17
ES2286033T3 (es) 2007-12-01

Similar Documents

Publication Publication Date Title
CY1121353T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
YU19903A (sh) Novi receptor nukleinskih kiselina i polipeptida
YU9403A (sh) Anti-dualna antitela integrina, kompozicije, postupci i primene
DE69824013D1 (de) Impfstoff gegen hpv
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
DE69431404D1 (de) Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe
BR0315275A (pt) Anticorpos que se ligam a receptor de eritropoietina
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
PT1083903E (pt) Indenopirrolocarbazoles em ponte
ATE412649T1 (de) Substituierte heteroarylbenzofuransäuren
ATE460923T1 (de) Lyophilisierung von virosomen
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
IL196900A (en) Autologous T cell vaccine compositions
DE60235836D1 (de) Ahren und verwendung davon
DK1278868T3 (da) Muteret form af arginindeiminase
TW200508246A (en) Anti-dengue virus antibodies, compositions, methods and uses
DE60118359D1 (de) Humanische pellino-polypeptide
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
ATE424217T1 (de) Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
ATE359811T1 (de) Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe
ATE476987T1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
ATE349520T1 (de) Gewebezementproteine aus rhipicephalus appendiculatus
ATE313628T1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
ATE346924T1 (de) P-glycoproteine und ihre verwendungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1204420

Country of ref document: EP